0001144204-17-054703.txt : 20171030 0001144204-17-054703.hdr.sgml : 20171030 20171030131109 ACCESSION NUMBER: 0001144204-17-054703 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20171030 DATE AS OF CHANGE: 20171030 EFFECTIVENESS DATE: 20171030 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Envisagenics, Inc. CENTRAL INDEX KEY: 0001699688 IRS NUMBER: 465496412 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-281766 FILM NUMBER: 171161523 BUSINESS ADDRESS: STREET 1: 335 MADISON AVE STREET 2: 3RD FLOOR CITY: NEW YORK STATE: NY ZIP: 10017-4616 BUSINESS PHONE: (516) 847-5485 MAIL ADDRESS: STREET 1: 335 MADISON AVE STREET 2: 3RD FLOOR CITY: NEW YORK STATE: NY ZIP: 10017-4616 D/A 1 primary_doc.xml X0708 D/A LIVE 0001699688 Envisagenics, Inc. 335 MADISON AVE 3RD FLOOR NEW YORK NY NEW YORK 10017-4616 (516) 847-5485 DELAWARE None None Corporation true 2014 Maria Luisa Pineda 335 Madison Avenue 3rd Floor New York NY NEW YORK 10017-4616 Executive Officer Director Promoter Martin Akerman 335 Madison Avenue 3rd Floor New York NY NEW YORK 10017-4616 Executive Officer Director Promoter Biotechnology Decline to Disclose 06b true 0001144204-17-012692 2017-03-16 false true Convertible Promissory Notes convertible into Equity Securities false 0 2500000 2500000 0 false 6 0 0 0 false Envisagenics, Inc. /s/ Maria Luisa Pineda Maria Luisa Pineda Co-President 2017-10-16